Literature DB >> 23195777

Noninvasive monitoring of microvascular changes with partial irradiation using dynamic contrast-enhanced and blood oxygen level-dependent magnetic resonance imaging.

Yu-Chun Lin1, Jiun-Jie Wang, Ji-Hong Hong, Yi-Ping Lin, Chung-Chi Lee, Yau-Yau Wai, Shu-Hang Ng, Yi-Ming Wu, Chun-Chieh Wang.   

Abstract

PURPOSE: The microvasculature of a tumor plays an important role in its response to radiation therapy. Dynamic contrast-enhanced magnetic resonance imaging (DCE MRI) and blood oxygen level-dependent (BOLD) MRI are both sensitive to vascular characteristics. The present study proposed a partial irradiation approach to a xenograft tumor to investigate the intratumoral response to radiation therapy using DCE and BOLD MRI. METHODS AND MATERIALS: TRAMP-C1 tumors were grown in C57BL/6J mice. Partial irradiation was performed on the distal half of the tumor with a single dose of 15 Gy. DCE MRI was performed to derive the endothelium transfer constant, K(trans), using pharmacokinetic analysis. BOLD MRI was performed using quantitative R2 measurements with carbogen breathing. The histology of the tumor was analyzed using hematoxylin and eosin staining and CD31 staining to detect endothelial cells. The differences between the irradiated and nonirradiated regions of the tumor were assessed using K(trans) values, ΔR2 values in response to carbogen and microvascular density (MVD) measurements.
RESULTS: A significantly increased K(trans) and reduced BOLD response to carbogen were found in the irradiated region of the tumor compared with the nonirradiated region (P<.05). Histologic analysis showed a significant aggregation of giant cells and a reduced MVD in the irradiated region of the tumor. The radiation-induced difference in the BOLD response was associated with differences in MVD and K(trans).
CONCLUSIONS: We demonstrated that DCE MRI and carbogen-challenge BOLD MRI can detect differential responses within a tumor that may potentially serve as noninvasive imaging biomarkers to detect microvascular changes in response to radiation therapy.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23195777     DOI: 10.1016/j.ijrobp.2012.10.022

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  Contrast-Enhanced Ultrasound to Detect Early Microvascular Changes in Skeletal Muscle after High-Dose Radiation Treatment.

Authors:  Nima Nabavizadeh; Yue Qi; Andy Kaempf; Yiyi Chen; James A Tanyi; Jonathan R Lindner; Melinda D Wu
Journal:  Radiat Res       Date:  2019-12-16       Impact factor: 2.841

2.  Photoacoustic imaging of vascular hemodynamics: validation with blood oxygenation level-dependent MR imaging.

Authors:  Laurie J Rich; Mukund Seshadri
Journal:  Radiology       Date:  2014-11-20       Impact factor: 11.105

Review 3.  Functional MR Imaging Techniques in Oncology in the Era of Personalized Medicine.

Authors:  Matthias R Benz; Hebert Alberto Vargas; Evis Sala
Journal:  Magn Reson Imaging Clin N Am       Date:  2015-09-26       Impact factor: 2.266

4.  Developing oxygen-enhanced magnetic resonance imaging as a prognostic biomarker of radiation response.

Authors:  Derek A White; Zhang Zhang; Li Li; Jeni Gerberich; Strahinja Stojadinovic; Peter Peschke; Ralph P Mason
Journal:  Cancer Lett       Date:  2016-06-03       Impact factor: 8.679

5.  Nintedanib antiangiogenic inhibitor effectiveness in delaying adenocarcinoma progression in Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP).

Authors:  Raquel Frenedoso da Silva; Ellen Nogueira-Pangrazi; Larissa Akemi Kido; Fabio Montico; Sarah Arana; Dileep Kumar; Komal Raina; Rajesh Agarwal; Valéria Helena Alves Cagnon
Journal:  J Biomed Sci       Date:  2017-05-12       Impact factor: 8.410

6.  Early Response Monitoring Following Radiation Therapy by Using [18F]FDG and [11C]Acetate PET in Prostate Cancer Xenograft Model with Metabolomics Corroboration.

Authors:  Yi-Hsiu Chung; Cheng-Kun Tsai; Chiun-Chieh Wang; Hsi-Mu Chen; Kuan-Ying Lu; Han Chiu; Yu-Chun Lin; Tzu-Chen Yen; Gigin Lin
Journal:  Molecules       Date:  2017-11-10       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.